Vertex Pharma, US92532F1003

Vertex Pharmaceuticals stock at EUR 492.55, up 1.10%

Published on 11/16/2026 at 08:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vertex Pharmaceuticals is a US pharmaceutical company. On Xetra, the stock closed at EUR 487.20 on Friday, November 13, 2026.

Key facts for investors

  • Vertex Pharmaceuticals is a US pharmaceutical company.
  • The company is included in the S&P 500.
Vertex Pharma, US92532F1003, Illustration mit AI erstellt.

Vertex Pharmaceuticals stock traded at 492.55 euros on Lang & Schwarz at 08:40 CET on Monday, November 16, 2026, 1.10 percent above the Xetra close of Friday, November 13, at 487.20 euros.

Boerse Frankfurt lists Vertex Pharmaceuticals as a US pharmaceutical company and includes the company in the S&P 500.

The S&P 500 remains the relevant market barometer for US-listed shares.

More news and analyses on Vertex Pharmaceuticals stock.

Disclaimer...
en | US92532F1003 | VERTEX PHARMA | boerse | 70519850 | bgmi